Laparoscopic gastric tube formation with pyloromyotomy for reconstruction in patients with esophageal cancer.
10.4174/astr.2015.89.3.117
- Author:
Jin Won LEE
1
;
Sook Whan SUNG
;
Jae Kil PARK
;
Cho Hyun PARK
;
Kyo Young SONG
Author Information
1. Department of Surgery, The Catholic University of Korea College of Medicine, Seoul, Korea. skygs@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Esophageal cancer;
Minimally invasive surgical procedures;
Laparoscopy;
Feasibility studies
- MeSH:
Axis, Cervical Vertebra;
Esophageal Neoplasms*;
Esophagectomy;
Feasibility Studies;
Humans;
Laparoscopy;
Length of Stay;
Lymph Node Excision;
Operative Time;
Postoperative Complications;
Surgical Procedures, Minimally Invasive
- From:Annals of Surgical Treatment and Research
2015;89(3):117-123
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To analyze the benefit and feasibility of this procedure compared with those of open method. METHODS: Abdominal procedure includes laparoscopic gastric mobilization, celiac axis lymph node dissection, formation of the gastric tube, and pyloromyotomy. The actual procedure performed during open surgery is the same as those of laparoscopic surgery except for the main incision. Minimally invasive esophagectomy (MIE) was performed on 54 patients with esophageal cancer. The short-term outcomes, including postoperative complications were analyzed and compared with 44 cases of open method. RESULTS: Although the total operative time was not different between 2 groups (349.8 minutes vs. 374.8 minutes, P = 0.153), the operation time of abdominal procedure was shorter in laparoscopic group (90.6 minutes vs. 162.1 minutes, P < 0.001). Operation related complications and hospital stay were not significantly different between the 2 groups. The number of transfused patients was significantly smaller in laparoscopic group (11.1% vs. 27.9%, P = 0.030). CONCLUSION: Laparoscopic gastric tubing with pyloromyotomy is a feasible and safe treatment option for patients with esophageal cancer.